419
Participants
Start Date
June 12, 2020
Primary Completion Date
May 1, 2024
Study Completion Date
September 22, 2036
Cilta-cel
Cilta-cel infusion will be administered at a target dose of 0.75 \* 10\^6 CAR-positive viable T cells/kilogram (kg).
Pomalidomide
Pomalidomide 4 mg will be administered orally.
Bortezomib
Bortezomib 1.3 milligram per meter square (mg/m\^2) will be administered subcutaneously (SC).
Dexamethasone
Dexamethasone 20 mg/day (10mg/day for participants \>75 years of age) (on bortezomib treatment days and the days following bortezomib treatment) will be administered orally in PVd treatment; and orally or intravenous (IV) at 40 mg weekly (20mg weekly for participants \>75 years of age) in DPd treatment.
Daratumumab
Daratumumab 1800 mg will be administered SC.
Royal Prince Alfred Hospital, Camperdown
Rigshospitalet, Copenhagen
Universitair Ziekenhuis - Antwerpen, Antwerp
Peter MacCallum Cancer Centre, Melbourne
UZ Leuven, Leuven
Alfred Health, Melbourne
Royal Brisbane and Womens Hospital, Herston
Royal Adelaide Hospital, Adelaide
Fiona Stanley Hospital, Murdoch
UZ Gent, Ghent
Memorial Sloan-Kettering Cancer Center, New York
A.O.U. Citta della Salute e della Scienza di Torino - Presidio Molinette, Turin
Attikon University General Hospital of Attica, Athens
University of Rochester Medical Center, Rochester
IRCCS Ospedale San Raffaele HSR, Milan
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Universitaetsklinikum Hamburg Eppendorf, Hamburg
University Of Maryland Medical Center, Baltimore
Duke University Medical Center, Durham
Hosp. Gral. Univ. Gregorio Maranon, Madrid
Hosp. Univ. 12 de Octubre, Madrid
Clinica Univ. de Navarra, Pamplona
Institut Universitaire du cancer de Toulouse-Oncopole, Toulouse
University Of Miami Leonard M Mille School Of Medicine SCCC, Miami
CHU de Montpellier Hopital Saint Eloi, Montpellier
University of Alabama at Birmingham, Birmingham
Hosp Clinico Univ de Salamanca, Salamanca
Azienda Opedaliero-Universitaria Policlinico Sant'orsola Malpighi di Bologna, Bologna
Hosp. Virgen Del Rocio, Seville
The Ohio State University, Columbus
C.H.U. Hotel Dieu - France, Nantes
Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut BadawczyOddz w Gliwicach, Gliwice
Universitaetsklinikum Koeln, Cologne
University of Iowa Hospitals and Clinics, Iowa City
Medical College Of Wisconsin, Milwaukee
Wisconsin Institutes for Medical Research, Madison
Mayo Clinic - Rochester, Rochester
CHRU de Lille Hopital Claude Huriez, Lille
Washington University School Of Medicine, St Louis
Sourasky Medical Center, Tel Aviv
University of Kansas, Westwood
Centre hospitalier Lyon-Sud, Pierre-Bénite
Klinikum der Eberhard Karls Universitaet Abt fur innere Med II Haematologie Onkologie Germany, Tübingen
Sheba Medical Center, Ramat Gan
Hopital Saint Louis, Paris
Colorado Blood Cancer Institute, Denver
Huntsman Cancer Institute, Salt Lake City
Mayo Clinic Cancer Center-Scottsdale, Phoenix
CHU De Poitiers, Poitiers
Universitatsklinikum Wurzburg, Würzburg
Stanford University Medical Center, Stanford
Yale New Haven Hospital, New Haven
Hackensack University Medical Center, Hackensack
Centre Hospitalier Universitaire de Liege Domaine Universitaire du Sart Tilman, Liège
Universitatsklinikum Carl Gustvav Carus Dresden an der Technischen Universitat Dresden, Dresden
Universitaetsklinikum Leipzig, Leipzig
Hadassah University Hospita Ein Kerem, Jerusalem
Policlinico Universitario Agostino Gemelli, Roma
Kyushu University Hospital, Fukuoka
Kanazawa University Hospital, Kanazawa
University Hospital Kyoto Prefectural University of Medicine, Kyoto
Nagoya City University Hospital, Nagoya
Okayama University Hospital, Okayama
Hokkaido University Hospital, Sapporo
Tohoku University Hospital, Sendai
Japanese Red Cross Medical Center, Shibuya City
VU Medisch Centrum, Amsterdam
University Medical Center Groningen, Groningen
Erasmus MC, Rotterdam
UMC Utrecht, Utrecht
Uniwersyteckie Centrum Kliniczne, Gdansk
Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan
Instytut Hematologii i Transfuzjologii, Warsaw
Seoul National University Hospital, Seoul
Samsung Medical Center, Seoul
The Catholic University of Korea Seoul St Marys Hospital, Seoul
Inst. Cat. D'Oncologia-Badalona, Badalona
Hosp Clinic de Barcelona, Barcelona
Skane University Hospital, Lund
Karolinska Universitetssjukhuset Huddinge, Hematologiska Kliniken, Huddinge, Stockholm
Akademiska Sjukhuset, Uppsala
Queen Elizabeth Hospital, Birmingham
Bristol Haematology and Oncology Centre, Bristol
University Hospital Wales, Cardiff
University College Hospital, London
Kings College Hospital, London
Christie Hospital, Manchester
Freeman Hospital, Newcastle upon Tyne
Janssen Research & Development, LLC
INDUSTRY